These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 8432493

  • 21. Recent and remote memory dissociation: medication effects and hippocampal function in schizophrenia.
    Gilbertson MW, van Kammen DP.
    Biol Psychiatry; 1997 Oct 01; 42(7):585-95. PubMed ID: 9376455
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Plasma haloperidol levels and clinical response.
    Smith RC.
    Arch Gen Psychiatry; 1987 Dec 01; 44(12):1110-2. PubMed ID: 3689100
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
    Yasui-Furukori N, Kondo T, Mihara K, Suzuki A, Inoue Y, Kaneko S.
    J Clin Psychopharmacol; 2003 Oct 01; 23(5):435-40. PubMed ID: 14520118
    [Abstract] [Full Text] [Related]

  • 29. The effect of haloperidol on aldosterone secretion.
    Warner MD, Gillespie H, Pavlou SN, Nader S, Peabody CA.
    Psychoneuroendocrinology; 1992 Oct 01; 17(5):517-21. PubMed ID: 1484918
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Haloperidol.
    Med Lett Drugs Ther; 1967 Sep 08; 9(18):70-1. PubMed ID: 5233811
    [No Abstract] [Full Text] [Related]

  • 32. Somatostatin-like immunoreactivity in CSF in schizophrenic patients during haloperidol treatment.
    Jolkkonen J, Pitkänen A, Riekkinen PJ, Korpi ER, Kaufmann CA, Weinberger DR.
    Biol Psychiatry; 1992 May 01; 31(9):962-4. PubMed ID: 1637934
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serum level of haloperidol and its clinical significance.
    Itoh H, Yagi G, Ohtsuka N, Iwamura K, Ichikawa K.
    Prog Neuropsychopharmacol; 1980 May 01; 4(2):171-83. PubMed ID: 7403350
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The "social chemistry" of pharmacological discovery: the haloperidol story. An interview with Dr. Paul Janssen, January 21, 1986. Interview by Stanley Einstein.
    Janssen P.
    Int J Addict; 1992 Mar 01; 27(3):331-46. PubMed ID: 1563889
    [No Abstract] [Full Text] [Related]

  • 37. Fluid intake patterns in schizophrenia and normal controls.
    Lawson WB, Roy S, Parent M, Herrera J, Karson C, Bigelow L.
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan 01; 16(1):39-44. PubMed ID: 1557505
    [Abstract] [Full Text] [Related]

  • 38. Lithium-haloperidol combination and brain damage.
    Prakash R.
    Lancet; 1982 Jun 26; 1(8287):1468-9. PubMed ID: 6123744
    [No Abstract] [Full Text] [Related]

  • 39. Haloperidol plasma level monitoring in psychiatric patients.
    Morselli PL, Zarifian E, Cuche H, Bianchetti G, Cotterau MJ, Deniker P.
    Adv Biochem Psychopharmacol; 1980 Jun 26; 24():529-36. PubMed ID: 7405674
    [No Abstract] [Full Text] [Related]

  • 40. Alprazolam in the emergency treatment of schizophrenia.
    Monfort JC.
    Am J Psychiatry; 1993 Feb 26; 150(2):358. PubMed ID: 8422106
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.